EPHA2 mutations have been associated with lymph node metastasis in CCA and targeting the phosphorylation of EPHA2 at Ser897 has shown effectiveness in inhibiting metastasis [116]. The gene discussed is EPHA2; the disease is cholangiocarcinoma.